Meilleure Health International Industry Group Ltd. manufactures and distributes medical products. The Company produces pharmaceutical drugs, healthcare products, and other products. Meilleure Health International Industry Group also operates researches and development businesses.

Meilleure Health International  (2327 HK)

Notification Letter To Non-Registered Shareholders

Notification Letter To Registered Shareholders

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2024

Announcements and Notices - [Interim Results]

Interim Results Announcement
For The Six Months Ended 30 June 2024

Announcements and Notices - [Date of Board Meeting]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Notification Letter To Non-Registered Shareholders

Notification Letter To Registered Shareholders

Interim Report 2024

Interim Results Announcement For The Six Months Ended 30 June 2024

Date Of Board Meeting